Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Research article

Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review

Authors: K. E. Gallagher, E. Kadokura, L. O. Eckert, S. Miyake, S. Mounier-Jack, M. Aldea, D. A. Ross, D. Watson-Jones

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

Completion of multiple dose vaccine schedules is crucial to ensure a protective immune response, and maximise vaccine cost-effectiveness. While barriers and facilitators to vaccine uptake have recently been reviewed, there is no comprehensive review of factors influencing subsequent adherence or completion, which is key to achieving vaccine effectiveness. This study identifies and summarises the literature on factors affecting completion of multi-dose vaccine schedules by adolescents.

Methods

Ten online databases and four websites were searched (February 2014). Studies with analysis of factors predicting completion of multi-dose vaccines were included. Study participants within 9–19 years of age were included in the review. The defined outcome was completion of the vaccine series within 1 year among those who received the first dose.

Results

Overall, 6159 abstracts were screened, and 502 full texts were reviewed. Sixty one studies were eligible for this review. All except two were set in high-income countries. Included studies evaluated human papillomavirus vaccine, hepatitis A, hepatitis B, and varicella vaccines. Reported vaccine completion rates, among those who initiated vaccination, ranged from 27 % to over 90 %. Minority racial or ethnic groups and inadequate health insurance coverage were risk factors for low completion, irrespective of initiation rates. Parental healthcare seeking behaviour was positively associated with completion. Vaccine delivery in schools was associated with higher completion than delivery in the community or health facilities. Gender, prior healthcare use and socio-economic status rarely remained significant risks or protective factors in multivariate analysis.

Conclusions

Almost all studies investigating factors affecting completion have been carried out in developed countries and investigate a limited range of variables. Increased understanding of barriers to completion in adolescents will be invaluable to future new vaccine introductions and the further development of an adolescent health platform.
PROSPERO reg# CRD42014006765.
Appendix
Available only for authorised users
Literature
1.
Beharry MS, Coles MS, Burstein GR. Adolescent immunization update. Pediatr Infect Dis J. 2011;30(9):787–90.CrossRefPubMed
2.
Ackerman LK. Update on immunizations in children and adolescents. Am Fam Physician. 2008;77(11):1561–8.PubMed
3.
4.
5.
World Health Organization. Hepatitis B vaccine - WHO position paper in weekly epidemiological record. Geneva: WHO; 2009. p. 405.
6.
7.
World Health Organization. Varicella vaccines, WHO position paper. In: Weekly epidemiological record. 1998. p. 241–8.
8.
World Health Organization, World Health Organization, Human Papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec. 2009;84(1):118–31.
9.
World Health Organization. Human Papillomavirus vaccines: WHO position paper October 2014. In: Weekly epidemiological record. 2014. p. 465–92.
10.
Strategic Advisory Group of Experts (SAGE) on Immunization. Evidence based recommendations on Human Papilloma Virus (HPV) vaccines schedules: background paper for SAGE discussions. Geneva: World Health Organization; 2014.
11.
Lazcano-Ponce E et al. Overcoming barriers to HPV vaccination: non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months. Vaccine. 2014;32(6):725–32.CrossRefPubMed
12.
Dobson SR et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA. 2013;309(17):1793–802.CrossRefPubMed
13.
Baldo V et al. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis. 2009;9.
14.
World Health Organization. WHO position paper on hepatitis A vaccines - June 2012. In: Weekly epidemiological record. 2012. p. 261–76.
15.
Cook RL et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health. 2010;47(6):596–9.CrossRefPubMed
16.
17.
Kessels SJ et al. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–56.CrossRefPubMed
18.
Lehmann C, Benson PA. Vaccine adherence in adolescents. Clin Pediatr (Phila). 2009;48(8):801–11.CrossRef
19.
Falagas ME, Zarkadoulia E. Factors associated with suboptimal compliance to vaccinations in children in developed countries: a systematic review. Curr Med Res Opin. 2008;24(6):1719–41.CrossRefPubMed
20.
21.
Etter DJ, Zimet GD, Rickert VI. Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol. 2012;24(5):305–10.CrossRefPubMed
22.
Briss PA et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18(1, Supplement 1):97–140.CrossRefPubMed
23.
24.
25.
26.
Moher D et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–41.CrossRefPubMed
27.
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] Available from www.​cochrane-handbook.​org. 2011, The Cochrane Collaboration.
28.
Binagwaho A et al. Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90(8):623–8.PubMedCentralCrossRefPubMed
29.
Seid M et al. Correlates of vaccination for hepatitis B among adolescents. Results from a parent survey. Arch Pediatr Adolesc Med. 2001;155:921–6.CrossRefPubMed
30.
Deeks SL, Johnson IL. Vaccine coverage during a school-based hepatitis B immunization program. Can J Public Health. 1998;89(2):98–101.PubMed
31.
Nelson JC et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a Vaccine Safety Datalink Study. (Special Issue: Influenza preparedness and response.). Am J Public Health. 2009;99(Supplement 2):S389–97.PubMedCentralCrossRefPubMed
32.
33.
Smith LM et al. Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an ontario cohort of grade 8 girls. BMC Public Health. 2011;11.
34.
Lions C, Pulcini C, Verger P. Papillomavirus vaccine coverage and its determinants in South-Eastern France. Med Mal Infect. 2013;43(5):195–201.CrossRefPubMed
35.
Macdonald V et al. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health. 2007;4(1):27–30.CrossRefPubMed
36.
Chao C et al. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc. 2009;84(10):864–70.PubMedCentralCrossRefPubMed
37.
Schluterman NH et al. Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine. 2011;29(21):3767–72.CrossRefPubMed
38.
Perkins RB et al. Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: a multicenter study. J Womens Health. 2012;21(8):813–20.CrossRef
39.
Dorell CG et al. Human papillomavirus vaccination series initiation and completion, 2008-2009.[Erratum appears in Pediatrics. 2012 Jul;130(1):166-8 Note: Dosage error in article text]. Pediatrics. 2011;128(5):830–9.CrossRefPubMed
40.
Neubrand TPL et al. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr. 2009;48(9):966–9.CrossRef
41.
Verdenius I et al. Predictors of three dose on-time compliance with HPV4 vaccination in a disadvantaged, underserved, safety net population in the US midwest. PLoS One. 2013;8:8.CrossRef
42.
43.
Tan W et al. The HPV vaccine: are dosing recommendations being followed? Vaccine. 2011;29(14):2548–54.CrossRefPubMed
44.
Niccolai LM, Mehta NR, Hadler JL. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med. 2011;41(4):428–33.CrossRefPubMed
45.
Reiter PL, Katz ML, Paskett ED. Correlates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate. Vaccine. 2013;31(31):3121–5.PubMedCentralCrossRefPubMed
46.
47.
Middleman AB et al. Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health. 1999;25(5):323–7.CrossRefPubMed
48.
Harper DM et al. Quantifying clinical HPV4 dose inefficiencies in a safety net population. PLoS One. 2013;8:11.
49.
Moss JL et al. Organizational correlates of adolescent immunization: Findings of a state-wide study of primary care clinics in North Carolina. Vaccine. 2013;31(40):4436–41.PubMedCentralCrossRefPubMed
50.
Laz TH, Rahman M, Berenson AB. An update on human papillomavirus vaccine uptake among 11-17 year old girls in the United States: National Health Interview Survey, 2010. Vaccine. 2012;30(24):3534–40.PubMedCentralCrossRefPubMed
51.
Sakou II et al. Vaccination coverage among adolescents and risk factors associated with incomplete immunization. Eur J Pediatr. 2011;170(11):1419–26.CrossRefPubMed
52.
Brotherton JML et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust. 2013;199(9):614–7.CrossRefPubMed
53.
Gold R et al. Completion and timing of the three-dose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon. Prev Med. 2011;52(6):456–8.CrossRefPubMed
54.
Chao C et al. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009;99(6):1137–42.PubMedCentralCrossRefPubMed
55.
Gold R, Naleway A, Riedlinger K. Factors predicting completion of the human papillomavirus vaccine series. J Adolesc Health. 2013;52(4):427–32.CrossRefPubMed
56.
Markovitz AR et al. Association between maternal preventive care utilization and adolescent vaccination: it’s not just about Pap testing. J Pediatr Adolesc Gynecol. 2014;27(1):29–36.CrossRefPubMed
57.
Chao C et al. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010;171(3):357–67.PubMedCentralCrossRefPubMed
58.
Musto R et al. Social equity in human papillomavirus vaccination: a natural experiment in Calgary Canada. BMC Public Health. 2013;13.
59.
Sinka K et al. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland. J Epidemiol Community Health. 2014;68(1):57–63.CrossRefPubMed
60.
Bertaut A et al. HPV vaccination coverage in French girls attending middle and high schools: a declarative cross sectional study in the department of Cote d’Or. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):526–32.CrossRefPubMed
61.
62.
Kouyoumdjian FG, Bailowitz A. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic. Pediatr Infect Dis J. 2011;30(8):718–9.CrossRefPubMed
63.
Cleves MA. Hepatitis B vaccine compliance in inner city youth. J Adolesc Health. 1998;22(2):148.
64.
Bednarczyk RA et al. Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010. Vaccine. 2011;29(17):3138–43.CrossRefPubMed
65.
Brotherton JM, Mullins RM. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia. Cancer Epidemiol. 2012;36(3):298–302.CrossRefPubMed
66.
Monnat SM, Wallington SF. Is there an association between maternal Pap test use and adolescent human papillomavirus vaccination? J Adolesc Health. 2013;52(2):212–8.PubMedCentralCrossRefPubMed
67.
LaMontagne DS et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ. 2011;89(11):821–830B.PubMedCentralCrossRefPubMed
68.
69.
70.
Tung CS, Middleman AB. An evaluation of school-level factors used in a successful school-based hepatitis B immunization initiative. J Adolesc Health. 2005;37(1):61–8.CrossRefPubMed
71.
Lee GM et al. Adolescent immunizations: missed opportunities for prevention. Pediatrics. 2008;122(4):711–7.CrossRefPubMed
72.
Wong CA et al. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health. 2013;53(4):492–7.CrossRefPubMed
73.
Metadata
Title
Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review
Authors
K. E. Gallagher
E. Kadokura
L. O. Eckert
S. Miyake
S. Mounier-Jack
M. Aldea
D. A. Ross
D. Watson-Jones
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-2845-z

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue

Research article

Sarcopenic obesity and physical performance in middle aged women: a cross-sectional study in Northeast Brazil

Research article

Resilience of a FIT screening programme against screening fatigue: a modelling study

Research article

Clinical surveillance for human astrovirus in Monastir region, Tunisia

Research article

Effects of a randomized controlled intervention trial on return to work and health care utilization after long-term sickness absence

Research article

Cardiometabolic risk in young adults from northern Mexico: Revisiting body mass index and waist-circumference as predictors

Research article

Local spatial variations analysis of smear-positive tuberculosis in Xinjiang using Geographically Weighted Regression model